Business Wire

Oral-B and Straumann Partner on a Landmark Alliance for Scientific Education to Improve the Periodontal and Peri-Implant Health of Patients Worldwide

Share

Oral-B and Straumann, two of the world’s leading oral care companies, are proud to announce a new global alliance whose purpose is to elevate the importance of prevention in periodontal and peri-implant health. The alliance will set new standards in quality scientific education for dental professionals and help their patients achieve better long-term outcomes.

The Oral-B Straumann alliance has a long-term goal of delivering a holistic program of scientific events, professional courses, webinars and publications, co-created with and delivered by the world’s leading experts and thought leaders in dentistry.

The alliance will be launched on 17th June 2022 with a Sponsored Scientific Session at EuroPerio10 Copenhagen – the world’s leading congress in periodontology and implant dentistry – where both companies will also present their recent innovations for periodontal and peri-implant patients: Straumann Biomaterials solutions ranging from enhanced wound healing and bone regeneration to soft-tissue management and wound care and Oral-B iO Specialized Clean brush head, Oral-B iO10 & iOsense to empower patients in effective self-care.

“As patients around the world invest in dental implants, they need to recognize that self-care around implants is just as important as around their natural teeth. The Oral-B/Straumann Alliance will play an important role in enabling ongoing dialogue between dental professionals and their patients so both understand the most up to date science on prevention of implant-related diseases and promotion of periodontal health,” says J. Leslie Winston, Vice President, Global Health Care R&D, Procter & Gamble.

Arik Zucker, Vice President, Global Head of Biomaterials, Straumann Group, adds: “Prevention of tooth or implant loss is for many years an important topic for us in the Straumann Group. As one of the world’s leading dental implant companies, we work closely with experts from the research and clinical fields to address the issues caused by peri-implantitis and periodontitis. The Alliance with Oral-B complements our efforts and offers a solid ground for further scientific and educational activities that will enable more dental professionals to improve their patients’ lives.”

Oral-B & Straumann Alliance: Partnering to Amplify the Importance of Prevention

The vision for the Oral-B Straumann Alliance is ambitious: an unwavering commitment to amplifying the importance of prevention through scientific education, helping dental professionals and their implant and periodontal patients achieve better outcomes.

Starting with the Sponsored Scientific Session at Europerio10 in Copenhagen on 17th June 2022, the alliance will be rolled out over a series of scientific exchange activities that include a forthcoming scientific symposium at the American Academy of Periodontology annual meeting in October 2022, as well as continuing education courses, webinars and publications- all developed with and delivered by the world’s leading experts and thought leaders- focusing on the importance of preventive clinical and self-care for the life cycle of the implant and general periodontal health.

The Sponsored Scientific Session “Limiting periodontal and peri-implant diseases during and beyond the pandemic: from the chair to self-care.” will be presented at Europerio10 by Dr. Martina Stefanini (University of Bologna), Prof Giorgio Pagni (University of Milan) and Prof Filippo Graziani (University of Pisa). Reflecting on the importance and potential impact of the Oral-B Straumann alliance, Prof Graziani remarked: “I strongly believe that with the changes in the society and patients’ behaviors it is fundamental to provide a large array of solutions for general health. There are so many opportunities that any patient may get confused by the plethora of products and indications. Thus, this alliance should be cherished in order to simplify the life of our patients and provide additional benefits for their health.”

Periodontal Disease: the #1 cause of tooth loss

Tooth loss is a major global oral health concern: 69 % of 35-44-year-olds in the US have lost at least one permanent tooth1 while in Europe 30 % of 65-74-year-olds have no natural teeth left2. With periodontal disease being the number one cause of tooth loss in adults-and prevalent in up to 50 % of the global adult population- its impacts can have a detrimental effect on the quality of a patient’s life, with a growing volume of scientific evidence that consistently highlights the association between periodontal disease and a number of systemic conditions, such as Type 2 diabetes, cardiovascular disease and Alzheimer’s disease.3

The economic impacts of periodontal disease (both on the individual and society as a whole) are no less significant: A single tooth implant costs 2,000-5,000 euros and to protect their investment, patients must be educated on how to remove plaque (the dominant risk factor for oral disease) and prevent periodontal & peri-implant diseases, with dental professionals playing a central role in this process.

Prevention Pays Off

Studies show that the removal of 80-85 % of oral biofilm twice a day as part of a patient’s self-care routine can maintain oral and implant health.4 And as we emerge from the pandemic prevention of periodontal disease is more important now than ever, with recent research finding that Covid-19 patients with periodontitis are 3.5x more likely to be admitted to intensive care and 9x more likely to die than Covid-19 patients with healthy gums.5 Beyond the significant personal benefit to the patient, recent studies have also shown that eliminating the burden of gingivitis and increasing the diagnosis and treatment rate of periodontitis to 90% in 6 European countries shows a positive return on investment for society over a 10-year period.6

Trusted Science, Trusted Brands, Indispensable Partners for Dental Professionals

Both Oral-B & Straumann are innovation leaders in their respective fields: the former with its range of proven personal oral hygiene products the #1 dentist recommended brand worldwide and the latter as the world-leading brand for confidence in esthetic dentistry and a gold standard in implantology. With their extensive portfolios of breakthrough oral care products and biomaterials, Oral-B and Straumann will support the launch of the alliance by presenting to dental professionals an upcoming range of new innovations for successful patient outcomes:

Oral-B iO Specialized Clean Brush Head: Brushing personalized to the needs of Implant Patients

The highly anticipated Specialized Clean brush head with its distinctive bristle field designed with dental professionals exclusively for the Oral-B iO series of electric rechargeable toothbrushes combines oscillation-rotation with the gentle energy of microvibrations to effectively reach and clean around implant restorations and other hard-to-reach areas that require special focus.

Findings from a recent case study of implant patients who used the Oral-B iO9 round brush heads together with the Specialized Clean brush head showed a 62.7 % reduction in plaque 8 weeks after switching to iO from their regular toothbrush; in line with previously published research showing the superior oral hygiene benefits in favour of Oral-B iO versus a manual toothbrush. In a recent study, 3 times more patients with swollen gums who used Oral-B iO were categorized as generally healthy over an 8-week period compared to those patients using a manual toothbrush.7

Oral-B iO10 with iOsense: Technology for better self-care

Launching in September 2022, Oral-B iO10 with iOsense offers real-time coaching via Artificial Intelligence and the Oral-B app, making it even simpler to establish good oral hygiene habits without the need to bring your phone into the bathroom. The iOsense™ Smart Charger personalizes your clean with live coaching to guide how, when and where you brush by providing real-time feedback on your brushing via the LEDs built into the charger, ensuring the user brushes thoroughly, with optimal pressure and for the dental professional recommended duration.

Research shows a positive correlation between app usage and improved oral hygiene.8 And a recent analysis of 16.7 million anonymized real world brushing sessions using the Oral-B app and Oral-B® smart-connected oscillating-rotating toothbrushes found that real-time feedback using Position Detection resulted in:9

  • Excellent brushing thoroughness: with an average of 94% of brushing zones covered and with 8 out of 10 brushing sessions producing complete coverage.
  • Longer Brushing: Brushing sessions with real-time app feedback lasted on average 2m43s, 21.6 % longer than brushing sessions without the app and helping users ensure they brush for the dental professional recommended 2 minutes. With the average brushing session with a manual toothbrush reported to be just 46 seconds long there has never been a better time adopt interactive brush technology to help establish better brushing behaviors.

Straumann Biomaterials: proven technologies to help dental professionals set their patients up for success

Equally significant is the contribution to dentistry by Straumann, a global leader in the field of dental implants and an important player in the biomaterials market. Offering the industry’s most comprehensive biomaterials portfolio, Straumann provides dental professionals with a unique range in oral regeneration that covers a large range of indications, from enhanced wound healing and bone regeneration to soft-tissue management and wound care:

  • Straumann® Emdogain®: a unique gel containing enamel matrix derivative with an impressive scientifical background of over 1000 publications10, including multiple 10-year follow-up studies11, and over 25 years of clinical experience. Based on its success and thanks to a new, shorter, and thinner applicator, Emdogain® FL can now be applied by specialists, general practitioners, and dental hygienists in a flapless approach connected to the hygiene phase of the periodontal treatment.12
  • Jason® membrane – a pericardium-based collagen membrane with a long barrier function, tensile strength, and easy handling.13,14
  • Straumann® XenoGraft – an easy-to-handle bovine bone graft that provides long-term volume stability.
  • Labrida BioClean™ – a proven solution for effective debridement of teeth and dental implant surfaces as part of maintenance or treatment protocols provided by specialists, general practitioners, and even dental hygienists.15,16

About Oral-B®

Oral-B® exists to help people Brush Like a Pro. Oral-B® was founded in 1950 by a California periodontist, who invented an innovative toothbrush to help his patients achieve healthier teeth and gums at home. Oral-B® continues to stay true to his mission and is today the worldwide leader in the over $5 billion brushing market. Part of the Procter & Gamble Company, the brand manufactures electric toothbrushes and toothpaste for adults and children, oral irrigators, and interdental products.

About The Straumann Group

The Straumann Group (SIX: STMN) is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Anthogyr, ClearCorrect, Dental Wings, Medentika, Neodent, NUVO, Straumann and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials and digital solutions for use in tooth correction, replacement and restoration or to prevent tooth loss. Headquartered in Basel, Switzerland, the Group currently employs more than 9000 people worldwide. Its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.

__________________________
1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028797/#:~:text=Statistics%20provided%20by%20the%20American,of%20their%20permanent%20teeth6 (accessed April 2022)
2 https://www.euro.who.int/en/health-topics/disease-prevention/oral-health/data-and-statistics#:~:text=Dental%20caries%20and%20severe%20periodontal,cases%20per%20100%20000%20people (accessed April 2022)
3 https://www.scientificamerican.com/custom-media/a-scientific-approach-to-cleaning-your-mouth/ (accessed April 2022)
4 Wingrove S. Why personalized oral hygiene technology matters. Compend Contin Educ Dent. 2022;43(suppl 1):1-4
5 Marouf N, Cai W, Said KN, et al. Association between periodontitis and severity of COVID-19 infection: A case-control study. J Clin Periodontol 2021; 48(4): 483-91
6 Bouchard, Carner, Carter et al., Time to take gum disease seriously, The Economist Intelligence Unit, 2021
7 Grender J, Goyal CR, Qaqish J, Adam R. Int Dent J 2020 70 (Suppl 1) S7-S15
8 Tonetti, MS, Deng, K, Christiansen, A, et al.. J Clin Periodontol. 2020; 47: 1219– 1226.
9 Thurnay S, Adam R, Meyners M. Oral Health Prev Dent. 2022 Jan 20;20(1):1-10. doi: 10.3290/j.ohpd.b2572911. PMID: 35049247
10 According to PUBMED search for “Emdogain” or “enamel matrix derivative”
11 Sculean A, Kiss A, Miliauskaite A, Schwarz F, Arweiler NB, Hannig M. Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration. J Clin Periodontol. 2008 Sep;35(9):817-24
12 Graziani F, Gennai S, Petrini M, Bettini L, Tonetti M. Enamel matrix derivative stabilizes blood clot and improves clinical healing in deep pockets after flapless periodontal therapy: A Randomized Clinical Trial. J Clin Periodontol. 2019 Feb; 46(2):231-240.
13 Rothamel et al. 2012, Biocompatibility and Biodegradation of a Native, Porcine Pericardium Membrane. Results from in vitro/in vivo Examination, J. Int J Oral Maxillofac Implants, 27(1):146-54.
14 Barbeck et al. 2015, Porcine dermis and pericardium-based, non-cross-linked materials induce multinucleated giant cells after their in vivo implantation: A physiological reaction? J Oral Implantol., 41(6):e267-81.
15 Wohlfahrt JC, Aass AM, Koldsland OC: Treatment of peri-implant mucositis with a chitosan brush-A pilot randomized clinical trial. Int J Dent Hyg 2019;17:170-176.
16 Wohlfahrt JC, Evensen BJ, Zeza B, Jansson H, Pilloni A, Roos-Jansaker AM, Di Tanna GL, Aass AM, Klepp M, Koldsland OC: A novel non-surgical method for mild peri-implantitis- a multicenter consecutive case series. Int J Implant Dent 2017;3:38.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Corporate:
Procter & Gamble GmbH, Sulzbacher Straße 40, 65824 Schwalbach am Taunus,
Boris Atlas
atlas.b@pg.com

Institut Straumann AG, Peter Merian-Weg 12, CH-4052 Basel, Switzerland
Laurentiu Motoc
laurentiu.motoc@straumann.com

Media:
MSL Germany, Otto-Messmer-Straße 1, 60314 Frankfurt am Main
Christina Meyer
christina.meyer@mslgroup.com

Procter & Gamble IO sa, 47 route de St-Georges, 1213 Petit Lancy, Switzerland
Paola Mulas
mulas.p@pg.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SCENTMATIC's AI "KAORIUM" Debuts at THAMEEN Fragrance Launch in London's Selfridges4.7.2025 12:13:00 EEST | Press release

SCENTMATIC Inc., a leader in scent digitalization, introduced its AI-powered scent-to-language system, KAORIUM, at the THAMEEN Fragrance new product launch event. This pivotal event took place from June 5 to 11, 2025, at Selfridges department store in London, UK. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250703662207/en/ State of exhibition Global Expansion: KAORIUM Establishes UK Presence Europe leads the global fragrance market, with the UK projected to reach US$2.82 billion by 2033. Recognizing this, SCENTMATIC is rapidly expanding its international footprint. In May 2024, SCENTMATIC established its overseas subsidiary, KAORIUM, in London, appointing industry expert Ben Yanoushek as CEO. Official UK operations commenced on February 1, 2025, with the launch of its dedicated website: www.kaorium.com. KAORIUM Trialed at "Florentine Diamond" Launch Event The "Florentine Diamond" launch event for luxury brand THAMEEN Frag

Global Tourism Surging Ahead of Economic Growth, With Visits to Hit 30 Billion by 20344.7.2025 02:00:00 EEST | Press release

The World Economic Forum has today published a new report forecasting that the travel and tourism industry is projected to serve 30 billion tourist trips by 2034. Travel and Tourism at a Turning Point: Principles for Transformative Growth, produced in collaboration with Kearney and the Ministry of Tourism Saudi Arabia, reveals a projected $16 trillion contribution to global GDP by the same year—representing more than 11% of the total world economy, according to World Travel & Tourism Council estimates. The report also found that the sector is expanding 1.5 times faster than the global economy, generating significant commercial opportunities as long as the mounting challenges of climate change, labour shortages and infrastructure gaps are addressed. Inbound and outbound trips increasing fast Asia is on track to become the world’s fastest-growing tourism economy, with the direct travel and tourism GDP contribution expected to exceed 7% across the region by 2034. Notably, India and China

The 2025-2026 World Branding Awards Animalis Edition Honouring Leading Pet and Animal Brands Globally3.7.2025 22:00:00 EEST | Press release

The 2025-2026 World Branding Awards Animalis Edition marked its fifth instalment, bringing together leading pet and animal brands from all around the world. These brands were celebrated for their outstanding achievements, earning recognition as National, Regional, and Global Winners. The awards ceremony, held at Vienna's prestigious Hofburg Palace, welcomed winners across diverse categories, including pet food, retail, wellness, pet exhibitions, and aquatic products. Mounia Berrada-Gouzi expertly hosted the evening, which culminated in a grand celebration of brand excellence. “The Animalis Edition of the World Branding Awards recognises brands that have achieved the highest distinction—genuine recognition in the hearts and minds of consumers. Tonight, we honour those whose names resonate globally, whose values inspire loyalty, and whose presence defines excellence in the pet and animal industry,” said Richard Rowles, Chairman of the World Branding Forum. Out of over 950 brands nominate

Venture Global Announces 20-Year Sales and Purchase Agreement with PETRONAS3.7.2025 15:59:00 EEST | Press release

Today, Venture Global, Inc. (NYSE: VG) announced the execution of a new 20-year Sales and Purchase Agreement (SPA) with PETRONAS LNG Ltd. (PLL), a subsidiary of the Malaysian state-owned oil and gas company, PETRONAS. Under the terms of the SPA, PETRONAS will purchase 1 million tonnes per annum (MTPA) of liquefied natural gas (LNG) from Venture Global’s third facility, CP2 LNG, for 20 years. This builds upon Venture Global’s existing agreement with PETRONAS for 1 MTPA of LNG supply from Plaquemines LNG. PETRONAS, a world-class partner in the LNG industry, joins other CP2 LNG customers in Europe, Asia and the rest of the world in a strategically important project to global energy supply and security. To date, approximately 10.75 MTPA of the 14.4 MTPA nameplate capacity for CP2 Phase One has been sold. About Venture Global Venture Global is a long-term, low-cost provider of U.S. LNG sourced from resource rich North American natural gas basins. Venture Global’s business includes assets ac

Frost & Sullivan Recognizes Novotech as 2025 Global Biotech CRO Company of the Year3.7.2025 15:05:00 EEST | Press release

In recognition of its innovation, client-focused delivery, and global impact, Novotech has been awarded the 2025 Global Biotechnology Contract Research Organization (CRO) Company of the Year by Frost & Sullivan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250703950144/en/ Novotech Wins Global CRO Award Novotech is a globally recognized full-service clinical CRO and scientific advisory firm, trusted by biotech and small- to mid-sized pharmaceutical companies to advance their drug development programs at every phase. With a global footprint spanning Asia-Pacific, North America, and Europe, Novotech supports over 5,000 clinical trial sites and a distributed team of experts delivering seamless, end-to-end solutions across geographies. “Novotech is redefining biotech-focused clinical research through AI-driven innovation, global expansion, and a client-embedded partnership model. With a clear vision to be the CRO of choice for

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye